Krüppel-like factor 4 regulates membranous and endochondral ossification

Experimental Cell Research

Volumn 318, Issue 4, 2012, Pages 311-325

  Michikami, Ikumi ^a   Fukushi, Toshiya ^a   Tanaka, Mariko ^a   Egusa, Hiroshi ^a   Maeda, Yoshinobu ^a   Ooshima, Takashi ^a   Wakisaka, Satoshi ^a   Abe, Makoto ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Bone marrow; Kruppel; Osteoblast; Osteocalcin; Osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGENASE 3; GELATINASE B; KRUPPEL LIKE FACTOR 4; OSTEOCALCIN; OSTEOPONTIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CARTILAGE; CARTILAGE CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PERICHONDRIUM; PRIMORDIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UPREGULATION;

MUS MUSCULUS;

EID: 84856100618     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.12.013     Document Type: Article

References (64)

1. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., Dacquin R., Mee P.J., McKee M.D., Jung D.Y., Zhang Z., Kim J.K., Mauvais-Jarvis F., Ducy P., Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469.
2. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5266-5270.
3. Wolf G. Energy regulation by the skeleton. Nutr. Rev. 2008, 66:229-233.
4. Kassi E., Papavassiliou A.G. A possible role of osteocalcin in the regulation of insulin secretion: human in vivo evidence?. J. Endocrinol. 2008, 199:151-153.
5. Fukumoto S., Martin T.J. Bone as an endocrine organ. Trends Endocrinol. Metab. 2009, 20:230-236.
6. Yoshizawa T., Hinoi E., Jung D.Y., Kajimura D., Ferron M., Seo J., Graff J.M., Kim J.K., Karsenty G. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 2009, 119:2807-2817.
7. Rached M.T., Kode A., Silva B.C., Jung D.Y., Gray S., Ong H., Paik J.H., DePinho R.A., Kim J.K., Karsenty G., Kousteni S. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J. Clin. Invest. 2010, 120:357-68.
8. Schuh R., Aicher W., Gaul U., Cote S., Preiss A., Maier D., Seifert E., Nauber U., Schroder C., Kemler R., et al. A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene. Cell 1986, 47:1025-1032.
9. Garrett-Sinha L.A., Eberspaecher H., Seldin M.F., de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 1996, 271:31384-31390.
10. Shields J.M., Christy R.J., Yang V.W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 1996, 271:20009-20017.
11. Shields J.M., Yang V.W. Two potent nuclear localization signals in the gut-enriched Kruppel-like factor define a subfamily of closely related Kruppel proteins. J. Biol. Chem. 1997, 272:18504-18507.
12. Shields J.M., Yang V.W. Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor. Nucleic Acids Res. 1998, 26:796-802.
13. McConnell B.B., Ghaleb A.M., Nandan M.O., Yang V.W. The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007, 29:549-557.
14. Ghaleb A.M., Nandan M.O., Chanchevalap S., Dalton W.B., Hisamuddin I.M., Yang V.W. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005, 15:92-96.
15. Chen Z., Couble M.L., Mouterfi N., Magloire H., Bleicher F. Spatial and temporal expression of KLF4 and KLF5 during murine tooth development. Arch. Oral Biol. 2009, 54:403-411.
16. Ohnishi S., Laub F., Matsumoto N., Asaka M., Ramirez F., Yoshida T., Terada M. Developmental expression of the mouse gene coding for the Kruppel-like transcription factor KLF5. Dev. Dyn. 2000, 217:421-429.
17. Segre J.A., Bauer C., Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
18. Katz J.P., Perreault N., Goldstein B.G., Lee C.S., Labosky P.A., Yang V.W., Kaestner K.H. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002, 129:2619-2628.
19. Ghaleb A.M., McConnell B.B., Nandan M.O., Katz J.P., Kaestner K.H., Yang V.W. Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res. 2007, 67:7147-7154.
20. Zhang W., Chen X., Kato Y., Evans P.M., Yuan S., Yang J., Rychahou P.G., Yang V.W., He X., Evers B.M., Liu C. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol. 2006, 26:2055-2064.
21. Ghaleb A.M., Aggarwal G., Bialkowska A.B., Nandan M.O., Yang V.W. Notch inhibits expression of the Kruppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol. Cancer Res. 2008, 6:1920-1927.
22. Canalis E., Deregowski V., Pereira R.C., Gazzerro E. Signals that determine the fate of osteoblastic cells. J. Endocrinol. Invest. 2005, 28:3-7.
23. Dacquin R., Starbuck M., Schinke T., Karsenty G. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn. 2002, 224:245-251.
24. Abe M., Michikami I., Fukushi T., Abe A., Maeda Y., Ooshima T., Wakisaka S. Hand2 regulates chondrogenesis in vitro and in vivo. Bone 2010, 46:1359-1368.
25. Hess J., Porte D., Munz C., Angel P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem. 2001, 276:20029-20038.
26. Shoichet S.A., Malik T.H., Rothman J.H., Shivdasani R.A. Action of the Caenorhabditis elegans GATA factor END-1 in Xenopus suggests that similar mechanisms initiate endoderm development in ecdysozoa and vertebrates. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4076-4081.
27. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 1995, 15:1858-1869.
28. Onishi M., Kinoshita S., Morikawa Y., Shibuya A., Phillips J., Lanier L.L., Gorman D.M., Nolan G.P., Miyajima A., Kitamura T. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 1996, 24:324-329.
29. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2007, 2:3081-3089.
30. Ortega N., Behonick D., Stickens D., Werb Z. How proteases regulate bone morphogenesis. Ann. N. Y. Acad. Sci. 2003, 995:109-116.
31. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422.
32. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 1999, 5:623-628.
33. Hiraki Y., Shukunami C. Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin. Connect. Tissue Res. 2005, 46:3-11.
34. Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., Bouillon R., Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 2002, 111:61-73.
35. Stickens D., Behonick D.J., Ortega N., Heyer B., Hartenstein B., Yu Y., Fosang A.J., Schorpp-Kistner M., Angel P., Werb Z. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004, 131:5883-5895.
36. Roodman G.D. Regulation of osteoclast differentiation. Ann. N. Y. Acad. Sci. 2006, 1068:100-109.
37. DeFranco D.J., Glowacki J., Cox K.A., Lian J.B. Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo. Calcif. Tissue Int. 1991, 49:43-50.
38. Glowacki J., Rey C., Glimcher M.J., Cox K.A., Lian J. A role for osteocalcin in osteoclast differentiation. J. Cell. Biochem. 1991, 45:292-302.
39. Glowacki J., Lian J.B. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ. 1987, 21:247-254.
40. Mundy G.R., Poser J.W. Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif. Tissue Int. 1983, 35:164-168.
41. Malone J.D., Teitelbaum S.L., Griffin G.L., Senior R.M., Kahn A.J. Recruitment of osteoclast precursors by purified bone matrix constituents. J. Cell Biol. 1982, 92:227-230.
42. Chenu C., Colucci S., Grano M., Zigrino P., Barattolo R., Zambonin G., Baldini N., Vergnaud P., Delmas P.D., Zallone A.Z. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J. Cell Biol. 1994, 127:1149-1158.
43. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
44. Geoffroy V., Ducy P., Karsenty G. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J. Biol. Chem. 1995, 270:30973-30979.
45. Lian J.B., Stein G.S., Javed A., van Wijnen A.J., Stein J.L., Montecino M., Hassan M.Q., Gaur T., Lengner C.J., Young D.W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 2006, 7:1-16.
46. Geiman D.E., Ton-That H., Johnson J.M., Yang V.W. Transactivation and growth suppression by the gut-enriched Kruppel-like factor (Kruppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 2000, 28:1106-1113.
47. Frendo J.L., Xiao G., Fuchs S., Franceschi R.T., Karsenty G., Ducy P. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J. Biol. Chem. 1998, 273:30509-30516.
48. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
49. Nandan M.O., Yang V.W. The role of Kruppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells. Histol. Histopathol. 2009, 24:1343-1355.
50. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
51. Price P.A. Gla-containing proteins of bone. Connect. Tissue Res. 1989, 21:51-57. discussion 57-60.
52. Kornak U. Animal models with pathological mineralization phenotypes. Joint Bone Spine 2011.
53. Zebboudj A.F., Imura M., Bostrom K. Matrix Gla protein, a regulatory protein for bone morphogenetic protein-2. J. Biol. Chem. 2002, 277:4388-4394.
54. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., Delaisse J.M. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 2000, 151:879-889.
55. Cackowski F.C., Anderson J.L., Patrene K.D., Choksi R.J., Shapiro S.D., Windle J.J., Blair H.C., Roodman G.D. Osteoclasts are important for bone angiogenesis. Blood 2010, 115:140-149.
56. Takimoto A., Nishizaki Y., Hiraki Y., Shukunami C. Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation. Dev. Biol. 2009, 332:196-211.
57. Feinberg M.W., Cao Z., Wara A.K., Lebedeva M.A., Senbanerjee S., Jain M.K. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem. 2005, 280:38247-38258.
58. Davis-Dusenbery B., Chan M., Reno K., Weisman A., Layne M., Lagna G., Hata A. Down-regulation of Kruppel-like Factor-4 (KLF4) by MicroRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-b and bone morphogenetic protein 4. J. Biol. Chem. 2011, 286:28097-28110.
59. Hu D., Wan Y. Regulation of Kruppel-like Factor 4 by anaphase promoting complex pathway is involved in TGF-b signaling. J. Biol. Chem. 2011, 286:6890-6901.
60. Gorski J.P. Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms. Crit. Rev. Oral Biol. Med. 1998, 9:201-223.
61. Maruyama Z., Yoshida C.A., Furuichi T., Amizuka N., Ito M., Fukuyama R., Miyazaki T., Kitaura H., Nakamura K., Fujita T., Kanatani N., Moriishi T., Yamana K., Liu W., Kawaguchi H., Komori T. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 2007, 236:1876-1890.
62. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., Wu H., Yu K., Ornitz D.M., Olson E.N., Justice M.J., Karsenty G. A twist code determines the onset of osteoblast differentiation. Dev. Cell 2004, 6:423-435.
63. Ai W., Zheng H., Yang X., Liu Y., Wang T.C. Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity. Nucleic Acids Res. 2007, 35:6137-6149.
64. Evans P.M., Zhang W., Chen X., Yang J., Bhakat K.K., Liu C. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem. 2007, 282:33994-34002.